Live Webinar
As global regulatory expectations continue to evolve alongside advances in biologics development and manufacturing, safety testing is entering a new era. The transition from traditional assays to recombinant reagents and rapid detection technologies is reshaping key quality control processes, including endotoxin, mycoplasma, and sterility testing. At the same time, the rise of advanced therapies such as cell and gene therapies is driving the need for greater efficiency and regulatory compliance.
This webinar will explore the latest technological innovations and regulatory trends in safety testing, and discuss practical strategies to achieve efficient and compliant quality control in modern biomanufacturing.
In this webinar you will learn how to:
- Understand key regulatory trends shaping modern biologics safety testing
- Evaluate the transition from traditional methods to recombinant and rapid technologies
- Identify critical safety testing challenges in advanced therapy development
- Implement efficient and compliant safety testing strategies in biomanufacturing
- Optimize quality control workflows to support faster and more flexible product release
Offered Free by: Biocompare
See All Resources from: Biocompare
